GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Gross Margin %

Optimind Pharma (XCNQ:OMND) Gross Margin % : 0.00% (As of Aug. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Optimind Pharma's Gross Profit for the three months ended in Aug. 2024 was C$0.04 Mil. Optimind Pharma's Revenue for the three months ended in Aug. 2024 was C$0.04 Mil. Therefore, Optimind Pharma's Gross Margin % for the quarter that ended in Aug. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Optimind Pharma's Gross Margin % or its related term are showing as below:


XCNQ:OMND's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 47.02
* Ranked among companies with meaningful Gross Margin % only.

Optimind Pharma had a gross margin of N/A% for the quarter that ended in Aug. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Optimind Pharma was 0.00% per year.


Optimind Pharma Gross Margin % Historical Data

The historical data trend for Optimind Pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Gross Margin % Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23 Feb24
Gross Margin %
- - -

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Optimind Pharma's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optimind Pharma's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's Gross Margin % falls into.



Optimind Pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Optimind Pharma's Gross Margin for the fiscal year that ended in Feb. 2024 is calculated as

Gross Margin % (A: Feb. 2024 )=Gross Profit (A: Feb. 2024 ) / Revenue (A: Feb. 2024 )
=0.1 / 0.123
=(Revenue - Cost of Goods Sold) / Revenue
=(0.123 - 0) / 0.123
=N/A %

Optimind Pharma's Gross Margin for the quarter that ended in Aug. 2024 is calculated as


Gross Margin % (Q: Aug. 2024 )=Gross Profit (Q: Aug. 2024 ) / Revenue (Q: Aug. 2024 )
=0 / 0.041
=(Revenue - Cost of Goods Sold) / Revenue
=(0.041 - 0) / 0.041
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Optimind Pharma  (XCNQ:OMND) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Optimind Pharma had a gross margin of N/A% for the quarter that ended in Aug. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Optimind Pharma Gross Margin % Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimind Pharma Business Description

Traded in Other Exchanges
N/A
Address
77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines